CompletedPhase 2ketamine
Study Testing Ketamine Sublingual Wafer After Wisdom Tooth Extraction
Sponsored by iX Biopharma Ltd.
NCT ID
NCT02356965
Target Enrollment
80 participants
Start Date
2014-12
Est. Completion
2015-02
About This Study
The purpose of the study is to test two different doses of ketamine sub-lingual (under the tongue) wafer against placebo to see how effective the medication is to treat moderate to severe pain after wisdom tooth extraction.
Conditions Studied
Interventions
- •Ketamine
- •Placebo (for Ketamine)
Eligibility
Age:18 Years - 38 Years
Healthy Volunteers:Yes
View full eligibility criteria
Healthy male and female subjects, ages 18-38 years old, who are scheduled to undergo two ipsilateral third molar extractions.
Study Locations (1)
Jean Brown Research
Salt Lake City, Utah, United States